Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Satyavrat Shukla | M | 52 | 3 years | |
| Frank Thomas | M | 54 | 7 years | |
| John Pottage | M | 71 | 6 years | |
| Scott Jackson | M | 59 | 4 years | |
| Patrick Volkert Vink | M | 60 | 9 years | |
| Cynthia Smith | F | 55 | 5 years | |
| Kathleen Tregoning | F | 53 | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Joel D. Sendek | M | 57 | 2 years | |
| Stephen DiPalma | M | 66 | 2 years | |
| Stephen Garbacz | M | 65 | - | |
| Jean-Francois Formela | M | 67 | 8 years | |
| Tamara Joseph | F | 61 | 4 years | |
| Cristina Larkin | F | 54 | - | |
| David Musselman | M | - | - | |
| Scott Peterson | M | - | - | |
| Carol Waldo | F | - | 3 years | |
| Troy Lister | M | - | - | |
| David Melnick | M | 72 | - | |
| John F. Tomayko | M | - | - | |
| Jay Blackington | M | - | - | |
| Thamil Annamalai | F | - |
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | 4 years |
| Steven Bryant Porter | M | 66 |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | 2 years |
| Vikas Goyal | M | 45 | 5 years | |
| Casper Breum | M | 57 | 3 years | |
| William Halter | M | 63 |
Xenogen Corp.
 Xenogen Corp. Medical SpecialtiesHealth Technology Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA. | 4 years |
| David Southwell | M | 63 | 2 years | |
| David J. Loury | M | 68 |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | 5 years |
| Williamson Z. Bradford | M | 62 |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | 3 years |
| Johan Kördel | M | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 29 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Thomas R. Parr
- Personal Network